Impact of Clostridium difficile Infection on Pediatric Inflammatory Bowel Disease

Journal of Pediatrics

Volumn 154, Issue 6, 2009, Pages 854-858

  Pascarella, Filomena ^a   Martinelli, Massimo ^a   Miele, Erasmo ^a   Del Pezzo, Mariassunta ^a   Roscetto, Emanuela ^a   Staiano, Annamaria ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CLOSTRIDIUM DIFFICILE TOXIN A; MESALAZINE; METHOTREXATE; PROTON PUMP INHIBITOR; STEROID;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE ACTIVITY; ENTERITIS; FEMALE; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD;

ADOLESCENT; BACTERIAL TOXINS; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; FEMALE; HUMANS; INFANT; INFLAMMATORY BOWEL DISEASES; MALE; RISK FACTORS;

EID: 67349197840     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2008.12.039     Document Type: Article

References (31)

1. Issa M., Vijayapal A., Graham M.B., Beaulieu D.B., Otterson M.F., Lundeen S., et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol 5 (2007) 345-351
2. Rodemann J.F., Dubberke E.R., Reske K.A., Seo da H., and Stone C.D. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol 5 (2007) 339-344
3. Ananthakrishnan A.N., McGinley E.L., and Binion D.G. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut 57 (2008) 205-210
4. Kelly C.P., Pothoulakis C., and LaMont T.J. Clostridium difficile colitis. N Engl J Med 330 (1994) 257-262
5. Redelings M.D., Sorvillo F., and Mascola L. Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg Infect Dis 13 (2007) 1417-1419
6. Bignardi G.E. Risk factors for Clostridium difficile infection. J Hosp Infect 40 (1998) 1-15
7. Greenfield C., Aguilar Ramirez J.R., Pounder R.E., Williams T., Danvers M., Marper S.R., et al. Clostridium difficile and inflammatory bowel disease. Gut 24 (1983) 713-717
8. Baumgart D.C., and Sandborn W.J. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 369 (2007) 1641-1657
9. Bousvaros A., Morley-Fletcher A., Pensabene L., and Cucchiara S. Research and clinical challenges in paediatric inflammatory bowel disease. Dig Liver Dis 40 (2008) 32-38
10. Irving P.M., and Gibson P.R. Infections and IBD. Nat Clin Pract Gastroenterol Hepatol 5 (2008) 18-27
11. Mylonaki M., Langmead L., Pantes A., Johnson F., and Rampton D.S. Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool. Eur J Gastroenterol Hepatol 16 (2004) 775-778
12. Stallmach A., and Carstens O. Role of infections in the manifestation or reactivation of inflammatory bowel diseases. Inflamm Bowel Dis 8 (2002) 213-218
13. Meyer A.M., Ramzan N.N., Loftus Jr. E.V., Heigh R.I., and Leighton J.A. The diagnostic yield of stool pathogen studies during relapses of inflammatory bowel disease. J Clin Gastroenterol 38 (2004) 772-775
14. Stone C.D. Prognosis in Clostridium difficile infection complicating inflammatory bowel disease. Gut 57 (2008) 150-152
15. Gryboski J.D. Clostridium difficile in inflammatory bowel disease relapse. J Pediatr Gastroenterol Nutr 13 (1991) 39-41
16. Chong S.K., Blackshaw A.J., Boyle S., Williams C.B., and Walker-Smith J.A. Histological diagnosis of chronic inflammatory bowel disease in childhood. Gut 26 (1985) 55-59
17. Lichtiger S., Present D., Kornbluth A., Gelerent I., Bauer J., Galler G., et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Eng J Med 330 (1994) 1841-1845
18. Hyams J.S., Ferry G.D., Mandel F.S., Gryboski J.D., Kibort P.M., Kirschner B.S., et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 12 (1991) 439-447
19. Staneck J.L., Weckbach L.S., Allen S.D., Siders J.A., Gilligan P.H., Coppitt G., et al. Multicenter evaluation of four methods for Clostridium difficile detection: ImmunoCard C difficile, cytotoxin assay, culture, and latex agglutination. J Clin Microbiol 34 (1996) 2718-2721
20. Schumacher G., Kollberg B., Sandstedt B., Jorup C., Grillner L., Ljungh A., et al. A prospective study of first attacks of inflammatory bowel disease and non-relapsing colitis: microbiologic findings. Scand J Gastroenterol 28 (1993) 1077-1085
21. Viget N., Vernier-Massouille G., Salmon-Ceron D., Yazdanpanah Y., and Colombel J.F. Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis. Gut 57 (2008) 549-558
22. Tremaine W.J., Bille J., Huizenga K.A., Washington J.A., and Ilstrup D.M. Factors which influence the occurrence of Clostridium difficile infections in inflammatory bowel disease [abstract]. Gastroenterology 4 (1983) 1337
23. Keighley M.R., Youngs D., Johnson M., Allan R.N., and Burdon D.W. Clostridium difficile toxin in acute diarrhoea complicating inflammatory bowel disease. Gut 23 (1982) 410-414
24. Wiström J., Norrby S.R., Myhre E.B., Eriksson S., Granström G., Lagergren L., et al. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother 47 (2001) 43-50
25. Johnson S., Clabots C.R., Linn F.V., Olson M.M., Peterson L.R., and Gerding D.N. Nosocomial Clostridium difficile colonisation and disease. Lancet 336 (1990) 97-100
26. Paltansing S., van den Berg R.J., Guseinova R.A., Visser C.E., van der Vorm E.R., and Kuijper E.J. Characteristics and incidence of Clostridium difficile-associated disease in The Netherlands, 2005. Clin Microbiol Infect 13 (2007) 1058-1064
27. McFarland L.V., Mulligan M.E., Kwok R.Y., and Stamm W.E. Nosocomial acquisition of C difficile infection. N Engl J Med 320 (1989) 204-210
28. Dial S., Alrasadi K., Manouykian C., Huang A., and Menzies D. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pomp inhibitors: cohort and case-control studies. CMAJ 171 (2004) 33-38
29. Dial S., Delaney J.A., Barkun A.N., and Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 294 (2005) 2989-2995
30. Hauben M., Horn S., Reich L., and Younus M. Association between gastric acid suppressants and Clostridium difficile colitis and community-acquired pneumonia: analysis using pharmacovigilance tools. Int J Infect Dis 11 (2007) 417-422
31. Aseeri M., Schroeder T., Kramer J., and Zackula R. Gastric acid suppression by proton pump inhibitors as a risk factor for Clostridium difficile-associated diarrhea in hospitalized patients. Am J Gastroenterol 103 (2008) 2308-2313